Identification of tumour-associated and germ line p53 mutations in canine mammary cancer

British Journal of Cancer

Volumn 81, Issue 3, 1999, Pages 409-415

  Veldhoen, N ^a   Watterson, J ^a   Brash, M ^b   Milner, J ^a  

^a UNIVERSITY OF YORK   (United Kingdom)

^b Battle Flatts Veterinary Clinic   (United Kingdom)

Author keywords

Canine p53; DNA mutation; Germline; Mammary cancer

Indexed keywords

COMPLEMENTARY DNA; PROTEIN P53;

ANIMAL CELL; ARTICLE; BREAST CANCER; BREEDING; CANCER SUSCEPTIBILITY; DNA SEQUENCE; DOG; EXON; GENE AMPLIFICATION; GENE INACTIVATION; GENE MUTATION; GENETIC POLYMORPHISM; GERM LINE; NONHUMAN; PRIORITY JOURNAL; REVERSE TRANSCRIPTION;

ADENOMA; ANIMALS; BASE SEQUENCE; CARCINOMA; DNA MUTATIONAL ANALYSIS; DNA, COMPLEMENTARY; DNA, NEOPLASM; DOG DISEASES; DOGS; EXONS; FEMALE; GENES, P53; MAMMARY NEOPLASMS, ANIMAL; MOLECULAR SEQUENCE DATA; PROTEIN CONFORMATION; RNA, MESSENGER; RNA, NEOPLASM; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0032861046     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjc.6690709     Document Type: Article

References (45)

1. Ara S, Lee PS, Hansen MF and Saya H (1990) Codon 72 polymorphism of the TP53 gene. Nucleic Acids Res 18: 4961
2. Berns EM, Klijn JG, Smid M, van Staveren IL, Look MP. van Putten WL and Fockens JA (1996) TP53 and MYC gene alterations independently predict poor prognosis in breast cancer patients. Genes Chromosomes Cancer 16: 170-179
3. Béroud C and Soussi T (1998) p53 gene mutation: software and database. Nucleic Acids Res 26: 200-204
4. Birch JM, Blair V, Kelsey AM, Evans DG, Harris M, Tricker KJ and Varley JM (1998) Cancer phenotype correlates with constitutional TP53 genotype in families with the Li-Fraumeni syndrome. Oncogene 17: 1061-1068
5. Casey G, Lopez ME, Ramos JC, Plummer SJ, Arboleda MJ, Shaughnessy M, Karlan B and Slamon DJ (1996) DNA sequence analysis of exons 2 through 11 and immunohistochemical staining are required to detect all known p53 alterations in human malignancies. Oncogene 13: 1971-1981
6. Chang H, Benchimol S, Minden MD and Messner HA (1994) Alterations of p53 and c-myc in the clonal evolution of malignant lymphoma. Blood 83: 452-459
7. Chu LL, Rutteman GR, Kong JMC, Ghahremani M, Schmeing M, Misdorp W, van Garderen E and Pelletier J (1988) Genomic organization of the canine p53 gene and its mutational status in canine mammary neoplasia. Breast Cancer Res Treat 50: 11-25
8. Cook A and Milner J (1990) Evidence for allosteric variants of wild-type p53, a tumour suppressor protein. Br J Cancer 61: 548-552
9. Devilee P, van Leeuwen IS, Voesten A, Rutteman GR, Vos JH and Cornelisse CJ (1994) The canine p53 gene is subject to somatic mutations in thyroid carcinoma. Anticancer Res 14: 2039-2046
10. Faille A, De Cremoux P, Extra JM, Linares G, Espic M, Bourstyn E, De Rocquancourt A. Giacchetti S. Marty M and Calvo F (1994) p53 mutations and overexpression in locally advanced breast cancers. Br J Cancer 69: 1145-1150
11. Gamble J and Milner J (1988) Evidence that immunological variants of p53 represent alternative protein conformations. Virology 162: 452-458
12. Gannon JV, Greaves R, Iggo R and Lane DP (1990) Activating mutations in p53 produce a common conformational effect. A monoclonal antibody specific for the mutant form. EMBO J 9: 1595-1602
13. Glebov, OK, McKenzie KF, White CA and Sukumar S (1994) Frequent p53 gene mutations and novel alleles in familial breast cancer. Cancer Res 54: 3703-3709
14. Hainaut P, Soussi T, Shomer B, Hollstein M, Greenblatt M, Hovig E, Harris CC and Montesano R (1997) Database of p53 gene somatic mutations in human tumors and cell lines: updated compilation and future prospects. Nucleic Acids Rev 25: 151-157
15. Hartmann A, Blaszyk H, Kovach JS and Sommer SS (1997) The molecular epidemiology of p53 gene mutations in human breast cancer. Trends Genet 13: 27-33
16. Helland Â, Langerod A, Johnsen H, Olsen AO, Skovlund E and Borresen-Dale A-L (1998) p53 polymorphism and risk of cervical cancer. Nature 396: 530-531
17. Hirano Y, Yamato K and Tsuchida N (1995) A temperature sensitive mutant of the human p53. Vall 38, arrests rat cell growth without induced expression of cip//waf//sdi/ after temperature shift-down. Oncogene 10: 1879-1885
18. Huang Y, Yin J and Meltzer SJ (1994) A unique p53 intragenic deletion flanked by short direct repeats results in loss of mRNA expression in a human esophageal carcinoma. Carcinogenesis 15: 1653-1655
19. Johnson AS, Couto CG and Weghorst CM (1998) Mutation of the p53 tumor suppressor gene in spontaneously occurring osteosarcomas of the dog. Carcinogenesis 19: 213-217
20. Kussie PH, Gorina S, Marcchal V, Elenbaas B, Moreau J, Levine AJ and Pavletich N (1996) Structure of the MDM2 oncoprotein bound to the p53 tumor suppressor transactivation domain. Science 274: 948-953
21. Lin J, Wu X, Chen J, Chang A and Levine AJ (1995) Functions of the p53 protein in growth-regulation and tumor suppression. Cold Spring Harbor Symp Quant Biol 59: 215-223
22. MacVean DW, Monlux AW, Anderson PS Jr, Silberg SL and Roszel JF (1978) Frequency of canine and feline tumors in a defined population. Vet Pathol 15: 700-715
23. Malkin D (1994) Germline p53 mutations and heritable cancer. Annu Rev Genet 28: 447-465
24. Martinez J, Georgoff I, Martinez J and Levine A (1991) Cellular localization and cell cycle regulation by a temperature-sensitive p53 protein. Genes Dev 5: 151-159
25. Mayr B, Schellander K, Schleger W and Reifinger M (1994) Sequence of an exon of the canine p53 gene-mutation in a papilloma. Br Vet J 150: 81-84
26. Mayr B, Schaffner W, Botto I, Reifinger M and Loupal G (1997) Canine tumour suppressor gene p53-mutation in a case of adenoma of circumanal glands. Vet Res Comm 21: 369-373
27. Mayr B, Dressler A, Reifinger M and Feil C (1998) Cytogenetic alterations in eight mammary tumors and tumor-suppressor gene p53 mutation in one mammary tumor from dogs. Am J Vet Res 59: 69-78
28. Minaguchi T, Kanamori Y, Matsushima M, Yoshikawa H, Taketani Y and Nakamura Y (1998) No evidence of correlation between polymorphism at codon 72 of p53 and risk of cervical cancer in Japanese patients with human papillomavirus 16/18 infection. Cancer Res 58: 4585-4586
29. Moll UM, Riou G and Levine AJ (1992) Two distinct mechanisms alter p53 in breast cancer: mutation and nuclear exclusion. Proc Natl Acad Sci USA 89: 7262-7266
30. Priester WA and McKay FW (1980) The occurrence of tumors in domestic animals. Natl Cancer Inst Monograph 54: 152-184
31. Rolley N, Butcher S and Milner J (1995) Specific DNA binding by different classes of human p53 mutants. Oncogene 11: 763-770
32. Rosenthal AN, Ryan A, Al-Jehani RM, Storey A, Harwood CA and Jacobs IJ (1998) p53 codon 72 polymorphism and risk of cervical cancer in UK. Lancet 352: 871-872
33. Seth A, Palli D, Mariano JM, Metcalf R, Venanzoni M, Bianchi S, Kottaridis SD and Papas TS (1994) P53 gene mutations in women with breast cancer and a previous history of benign breast disease. Eur J Cancer 30A: 808-812
34. Storey A, Thomas M, Kalita A, Harwood C, Gardiol D, Mantovani F, Breuer J, Leigh IM, Matlashewski G and Banks L (1998) Role of a p53 polymorphism in the development of human papillomavirus-associated cancer. Nature 393: 229-234
35. Strauss BS (1997) Silent and multiple mutations in p53 and the question of the hypermutability of tumors. Carcinogenesis 18: 1445-1452
36. Sun X-F, Johannsson O, Hâkansson S, Sellberg G, Nordenskjöld B, Olsson H and Borg A (1996) A novel p53 germline alteration identified in a late onset breast cancer kindred. Oncogene 13: 407-411
37. Tagawa M, Murata M and Kimura H (1998) Prognostic value of mutations and germ line polymorphism of the p53 gene in non-small cell lung carcinoma: association with clinicopathological features. Cancer Lett 128: 93-99
38. Tornaletti S and Pfeifer GP (1995) Complete and tissue-independent methylation of CpG sites in the p53 gene: implications for mutations in human cancers. Oncogene 10: 1493-1499
39. Van Leeuwen IS, Hellmen E, Cornelisse CJ, van den Burgh B and Rutteman GR (1996) P53 mutations in mammary tumor cell lines and corresponding tumor tissues in the dog. Anticancer Res 16: 3737-3744
40. van Leeuwen IS, Cornelisse CJ, Misdorp W, Goedegebuure SA, Kirpensteijn J and Runeman GR (1997) P53 gene mutations in ostensarcomas in the dog. Cancer Lett 111: 173-178
41. Veldhoen N and Milner J (1998) Isolation of canine p53 cDNA and detailed characterization of the full length canine p53 protein. Oncogene 16: 1077-1084
42. Veldhoen N, Stewart J, Brown R and Milner J (1998) Mutations of the p53 gene in canine lymphoma and evidence for germ line p53 mutations in the dog. Oncogene 16: 249-255
43. Venkatachalam S, Shi Y-P, Jones SN, Vogel H, Bradley A, Pinkel D and Donehower LA (1998) Retention of wild-type p53 in tumors from p53 heterozygous mice: reduction of p53 dosage can promote cancer formation. EMBO J 17: 4657-4667
44. Wada H, Asada M, Nakazawa S, Itoh H, Kobayashi Y, Inoue T, Fukumuro K, Chan LC, Sugita K, Hanada R, Akuta N, Kobayashi N and Mizutani S (1994) Clonal expansion of p53 mutant cells in leukemia progression in vitro. Leukemia 8: 53-59
45. Yamato K, Yamamoto M, Hirano Y and Tsuchida N (1995) A human temperature-sensitive p53 mutant p53val-138: modulation of the cell cycle, viability and expression of p53-responsive genes. Oncogene 11: 1-6